|
[1]
|
Fang, Y., Tian, S., Pan, Y., et al. (2020) Pyroptosis: A New Frontier in Cancer. Biomedicine & Pharmacotherapy, 121, Article ID: 109595. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Loveless, R., Bloomquist, R. and Teng, Y. (2021) Pyroptosis at the Forefront of Anticancer Immunity. Journal of Experimental & Clinical Cancer Research, 40, Article No. 264. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Du, T., Gao, J., Li, P., et al. (2021) Pyroptosis, Metabolism, and Tumor Immune Microenvironment. Clinical and Translational Medicine, 11, e492. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Xia, X., Wang, X., Cheng, Z., et al. (2019) The Role of Pyroptosis in Cancer: Pro-Cancer or Pro-“Host”? Cell Death & Disease, 10, Article No. 650. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Zou, J., Zheng, Y., Huang, Y., et al. (2021) The Versatile Gasdermin Family: Their Function and Roles in Diseases. Frontiers in Immunology, 12, Article 751533. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Xia, S., Zhang, Z., Magupalli, V.G., et al. (2021) Gasdermin D Pore Structure Reveals Preferential Release of Mature Interleukin-1. Nature, 593, 607-611. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Dai, Z., Liu, W.C., Chen, X.Y., et al. (2023) Gasdermin D-Mediated Pyroptosis: Mechanisms, Diseases, and Inhibitors. Frontiers in Immunology, 14, Article 1178662. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Hsu, S.K., Li, C.Y., Lin, I.L., et al. (2021) Inflammation-Related Pyroptosis, a Novel Programmed Cell Death Pathway, and Its Crosstalk with Immune Therapy in Cancer Treatment. Theranostics, 11, 8813-8835. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Wu, J., Wang, L. and Xu, J. (2022) The Role of Pyroptosis in Modulating the Tumor Immune Microenvironment. Biomarker Research, 10, Article No. 45. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Taabazuing, C.Y., Okondo, M.C. and Bachovchin, D.A. (2017) Pyroptosis and Apoptosis Pathways Engage in Bidirectional Crosstalk in Monocytes and Macrophages. Cell Chemical Biology, 24, 507-514.E4. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
He, W.T., Wan, H., Hu, L., et al. (2015) Gasdermin D Is an Executor of Pyroptosis and Required for Interleukin-1β Secretion. Cell Research, 25, 1285-1298. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Lv, T., Xiong, X., Yan, W., et al. (2022) Targeting of GSDMD Sensitizes HCC to Anti-PD-1 by Activating cGAS Pathway and Downregulating PD-L1 Expression. Journal for ImmunoTherapy of Cancer, 10, e004763. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Peng, J., Jiang, H., Guo, J., et al. (2020) CD147 Expression Is As-sociated with Tumor Proliferation in Bladder Cancer via GSDMD. BioMed Research International, 2020, Article ID: 7638975. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Qiao, L., Wu, X., Zhang, J., et al. (2019) α-NETA Induces Pyroptosis of Epithelial Ovarian Cancer Cells through the GSDMD/Caspase-4 Pathway. The FASEB Journal, 33, 12760-12767. [Google Scholar] [CrossRef]
|
|
[15]
|
Ma, Y., Chen, Y., Lin, C. and Hu, G. (2018) Biologi-cal Functions and Clinical Significance of the Newly Identified Long Non-Coding RNA RP1‑85F18.6 in Colorectal Cancer. Oncology Reports, 40, 2648-2658. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Wang, W., Chen, D., Jiang, M., et al. (2018) Downregulation of GSDMD Promotes Gastric Cancer Proliferation by Regulating Cell Cycle-Related Proteins. Journal of Digestive Dis-eases, 19, 74-83. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Hou, J., Hsu, J.M. and Hung, M.C. (2021) Molecular Mechanisms and Functions of Pyroptosis in Inflammation and Antitumor Immunity. Molecular Cell, 81, 4579-4590. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Qiu, S., Hu, Y. and Dong, S. (2021) Pan-Cancer Analysis Re-veals the Expression, Genetic Alteration and Prognosis of Pyroptosis Key Gene GSDMD. International Immunophar-macology, 101, Article ID: 108270. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Li, R., Zeng, X., Yang, M., et al. (2021) Antidiabetic DPP-4 In-hibitors Reprogram Tumor Microenvironment That Facilitates Murine Breast Cancer Metastasis through Interaction with Cancer Cells via a ROS-NF-Small ka, CyrillicB-NLRP3 Axis. Frontiers in Oncology, 11, Article ID: 728047. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Ju, M., Bi, J., Wei, Q., et al. (2021) Pan-Cancer Analysis of NLRP3 Inflammasome with Potential Implications in Prognosis and Immunotherapy in Human Cancer. Briefings in Bio-informatics, 22, bbaa345. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Liang, Q., Wu, J., Zhao, X., et al. (2021) Establishment of Tumor In-flammasome Clusters with Distinct Immunogenomic Landscape Aids Immunotherapy. Theranostics, 11, 9884-9903. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Janowski, A.M., Colegio, O.R., Hornick, E.E., et al. (2016) NLRC4 Sup-presses Melanoma Tumor Progression Independently of Inflammasome Activation. Journal of Clinical Investigation, 126, 3917-28. [Google Scholar] [CrossRef]
|
|
[23]
|
Fukuda, K., Okamura, K., Riding, R.L., et al. (2021) AIM2 Regulates An-ti-Tumor Immunity and Is a Viable Therapeutic Target for Melanoma. Journal of Experimental Medicine, 218, e20200962. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Kaplanov, I., Carmi, Y., Kornetsky, R., et al. (2019) Blocking IL-1β Reverses the Immunosuppression in Mouse Breast Cancer and Synergizes with Anti-PD-1 for Tumor Abrogation. Pro-ceedings of the National Academy of Sciences of the United States of America, 116, 1361-1369. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Guo, B., Fu, S., Zhang, J., et al. (2016) Targeting inflam-masome/IL-1 Pathways for Cancer Immunotherapy. Scientific Reports, 6, Article No. 36107. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Son, Y.I., Dallal, R.M. and Lotze, M.T. (2003) Combined Treatment with Interleukin-18 and Low-DoseInterleukin-2 Induced Regression of a Murine Sarcoma and Memory Response. Journal of Immunotherapy, 26, 234-240. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Derangere, V., Chevriaux, A., Courtaut, F., et al. (2014) Liver X Receptor β Activation Induces Pyroptosis of Human and Murine Colon Cancer Cells. Cell Death & Differentia-tion, 21, 1914-1924. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Degterev, A., Hitomi, J., Germscheid, M., et al. (2008) Identification of RIP1 Kinase as a Specific Cellular Target of Necrostatins. Nature Chemical Biology, 4, 313-321. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Lin, W., Chen, Y., Wu, B., et al. (2021) Identification of the Pyropto-sis-Related Prognostic Gene Signature and the Associated Regulation Axis in Lung Adenocarcinoma. Cell Death Dis-covery, 7, Article No. 161. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Zhang, Q., Tan, Y., Zhang, J., et al. (2022) Pyroptosis-Related Signature Predicts Prognosis and Immunotherapy Efficacy in Muscle-Invasive Bladder Cancer. Frontiers in Immunology, 13, Article 782982. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Wu, L.S., Liu, Y., Wang, X.W., et al. (2020) LPS Enhances the Chemosensitivity of Oxaliplatin in HT29 Cells via GSDMD-Mediated Pyroptosis. Cancer Management and Research, 12, 10397-10409. [Google Scholar] [CrossRef]
|
|
[32]
|
Zhou, Z., He, H., Wang, K., et al. (2020) Granzyme A from Cyto-toxic Lymphocytes Cleaves GSDMB to Trigger Pyroptosis in Target Cells. Science, 368, eaaz7548. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Gao, J., Qiu, X., Xi, G., et al. (2018) Downregulation of GSDMD Attenuates Tumor Proliferation via the Intrinsic Mitochondrial Apoptotic Pathway and Inhibition of EGFR/Akt Signaling and Predicts a Good Prognosis in Non-Small Cell Lung Cancer. Oncology Reports, 40, 1971-1984. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Yan, H., Luo, B., Wu, X., et al. (2021) Cisplatin Induces Pyroptosis via Activation of MEG3/NLRP3/Caspase-1/ GSDMD Pathway in Triple-Negative Breast Cancer. International Journal of Biological Sciences, 17, 2606-2621. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Wang, X., Li, H., Li, W., et al. (2020) The Role of Caspa-se-1/GSDMD-Mediated Pyroptosis in Taxol-Induced cEll Death and a Taxol-Resistant Phenotype in Nasopharyngeal Carcinoma Regulated by Autophagy. Cell Biology and Toxicology, 36, 437-457. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Chen, D., Guo, S., Tang, X., et al. (2022) Combination of Ru-thenium (II) Polypyridyl Complex Delta-Ru1 and Taxol Enhances the Anti-Cancer Effect on Taxol-Resistant Cancer Cells through Caspase-1/GSDMD-Mediated Pyroptosis. Journal of Inorganic Biochemistry, 230, Article ID: 111749. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Jiang, Y., Yang, Y., Hu, Y., et al. (2022) Gasdermin D Re-stricts Anti-Tumor Immunity during PD-L1 Checkpoint Blockade. Cell Reports, 41, Article ID: 111553. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Magna, M. and Pisetsky, D.S. (2014) The Role of HMGB1 in the Pathogenesis of Inflammatory and Autoimmune Diseases. Molecular Medicine, 20, 138-146. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Zhang, R., Chen, J., Mao, L., et al. (2020) Nobiletin Triggers Reactive Oxygen Species-Mediated Pyroptosis through Regulating Autophagy in Ovarian Cancer Cells. Journal of Ag-ricultural and Food Chemistry, 68, 1326-1336. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Pizato, N., Luzete, B.C., Kiffer, L., et al. (2018) Omega-3 Do-cosahexaenoic Acid Induces Pyroptosis Cell Death in Triple-Negative Breast Cancer Cells. Scientific Reports, 8, Article No. 1952. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Wang, L., Li, K., Lin, X., et al. (2019) Metformin Induces Hu-man Esophageal Carcinoma Cell Pyroptosis by Targeting the miR-497/PELP1 Axis. Cancer Letters, 450, 22-31. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Liao, P., Huang, W.H., Cao, L., et al. (2022) Low Expression of FOXP2 Predicts Poor Survival and Targets Caspase-1 to Inhibit Cell Pyroptosis in Colorectal Cancer. Journal of Cancer, 13, 1181-1192. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Chen, T., Wang, Z., Zhong, J., et al. (2022) Secoisolar-iciresinol Diglucoside Induces Pyroptosis by Activating Caspase-1 to Cleave GSDMD in Colorectal Cancer Cells. Drug Development Research, 83, 1152-1166. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Cheng, Z., Li, Z., Gu, L., et al. (2022) Ophiopogonin B Alleviates Cisplatin Resistance of Lung Cancer Cells by Inducing Caspase-1/GSDMD Dependent Pyroptosis. Journal of Cancer, 13, 715-727. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Zhao, Q., Feng, H., Yang, Z., et al. (2022) The Central Role of a Two-Way Positive Feedback Pathway in Molecular Targeted Therapies-Mediated Pyroptosis in Anaplastic Thyroid Can-cer. Clinical and Translational Medicine, 12, e727. [Google Scholar] [CrossRef] [PubMed]
|